Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
Crossref DOI link: https://doi.org/10.1186/s12936-018-2190-z
Published Online: 2018-01-22
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baird, J. Kevin
Battle, Katherine E.
Howes, Rosalind E.
Funding for this research was provided by:
Wellcome Trust (106680/Z/14/Z)
Article History
Received: 13 December 2017
Accepted: 15 January 2018
First Online: 22 January 2018